SHARES NEWS & ANALYSIS
- AbbVie Inc (2)
- GlaxoSmithKline PLC (2)
- Imperial Tobacco Group PLC (2)
- Shire PLC (2)
- Actelion Ltd (1)
- AstraZeneca PLC (1)
- BHP Billiton PLC (1)
- BTG PLC (1)
- Gilead Sciences Inc (1)
- Pfizer Inc (1)
19 November 2014Speciality pharma group Vectura is seeing royalty income ramp up and the group boasts a strong product portfolio
17 November 2014Stem cell specialist ReNeuron (RENE) will next year apply for a new clinical trial in biotech's promised land - the US
17 November 2014Reckitt Benckiser is the latest company to offload a division it considers surplus to requirements.
11 November 2014The commercial launch of a treatment for varicose veins underpinned a strong half for the speciality pharma group
05 November 2014Following the collapse of the deal with AbbVie (US:ABBV), Shire's directors are buying up stock in the speciality pharma group.
31 October 2014Medical devices company Tissue Regenix is looking to build on the success of its product launch in the US this year
31 October 2014Pfizer chief execuitve Ian Read has come to the defence of tax inversion deals, prompting speculation it will reapproach AstraZeneca.
31 October 2014Drugs giant GlaxoSmithKline (GSK) is considering the float of a minority stake in its shared HIV business ViiV Healthcare.